Lumen Analytics: A GPL Library in a Binary, a Patent Letter, and a Data Licence Stretched Too Far

Exposure. Static linking into a single binary is the classic case where the FastParse code and Lumen's engine form one combined work. Distribution of that binary triggers GPLv3 obligations: provide the complete corresponding source of the combined work under GPLv3, plus notices and licence text. The 'mere aggregation' defence covers separate programs communicating at arm's length - separate processes, sockets, command-line invocation - not a statically linked binary.

Options, ranked:

1. Replace FastParse with a permissively licensed (MIT/Apache-2.0) equivalent. Highest engineering cost, lowest residual legal risk, and it removes the dependency permanently. This is usually the right answer.
2. Obtain a commercial licence from the copyright holder if it is a dual-licensing project (needs the holder to own or control all contributions - check).
3. Re-architect to arm's-length separation (separate process, defined interface). Defensible, but this is a contested area and 'we put it in a subprocess' is not automatic insulation.
4. Comply and release the connector's source under GPLv3. Commercially destructive for a proprietary product, and the decision probably needs board input.

Two things Lumen must not miss:

• Ceasing distribution does not cure past distribution. Downstream recipients already have rights, and Lumen must notify affected customers.
• GPLv3 terminates automatically on breach, with a first-time cure window (typically 30 days). Receipt of the letter starts a clock. Respond, do not wait for the customer to discover it.

The patent allegation is separate - do not let the GPL fire-fight consume the patent response deadline.

Scope first. The indemnity covers third-party claims that the product infringes IP. Two coverage questions:

1. Open-source components. Many product indemnities exclude third-party or open-source components. Check. If excluded, the GPL allegation and any infringement claim rooted in FastParse fall outside the indemnity - which is the worst outcome for Lumen, because it is uninsured and un-capped by the contract at exactly the moment the customer is loudest.
2. Breach of licence versus infringement. A GPL claim framed as breach of a copyright licence may or may not fit an 'IP infringement' clause; the drafting decides it.

The 'Customer modifications' exclusion. It applies only to the extent a claim arises from the modification. It is a causation test, not a switch. If the customer changed configuration files and the claim concerns the core binary, the exclusion does not bite. If the customer modified and redistributed the connector, it may.

The cap. USD 480,000 caps damages, not everything:

• Injunctive relief is not capped. A court can restrain distribution of the connector; the commercial cost of a recall and a re-architecture dwarfs the cap.
• Defence costs are usually inside the cap unless carved out - check; if inside, legal fees erode the protection fast.
• Remedies the indemnity may promise (procure a licence, modify, refund) are often outside the cap and should be modelled.

Practical advice: notify the customer now under the contract's notice provisions if the contract requires it; late notice can void cover. Reserve rights on both the patent and GPL fronts, and get a valuation of the recall scenario before settlement discussions.

There are three separate permissions being assumed, and management has conflated them.

1. Use for product improvement. Training a model may be product improvement. Selling model weights is commercial exploitation of a new asset. Those are different purposes, and the licence covers one.
2. 'Anonymised' data. Undefined in the contract, which is the problem. If the records are pseudonymised rather than anonymised, they remain personal data and the premise fails. Even genuinely anonymised data can be re-identified by a model that memorises rare records.
3. Output ownership. The licence is silent on model weights, outputs and derivative works. Silence favours the customer's reading that nothing was granted beyond the stated purpose.

The commercial risk, not just the legal one. Reselling weights derived from customer data is the precise scenario customers now negotiate expressly against. Doing it first and arguing later will cost the enterprise accounts.

Recommended path:

• Do not proceed on the current wording. Seek express, purpose-limited permission with a clear statement of what is trained, what is retained and who owns the output.
• Offer a no-training opt-out and honour it technically, not just contractually.
• Apply technical controls: deduplication, differential privacy, memorisation testing against the training set before any release.
• If the model must be sold, sell it trained on data Lumen owns or has licensed for that purpose.
• Check the security and cross-border implications before moving any records between environments.